OR WAIT null SECS
May 02, 2009
Process steps, GMP documents, a purification vessel, and validation seem to disappear.
The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.
April 02, 2009
Obama's cost-containment and science-innovation initiatives need to overlap.
The financial and economic downturn is likey to have long-term implications for outsourcing.
The role of automation suppliers is transforming to meet the pharma industry's demand for change.
GMP agents report on old products, aseptic violations, and unexpected emotions.
March 02, 2009
USP's revised chapter on injectables could harm anticounterfeiting efforts and drug administration.
The source of a problem reveals itself after some investigation, or it may crash down on you.
February 02, 2009
GMP experts act fast to resolve some unusual and difficult problems.
To manage risk properly, industry must understand what it is and how to assess it